Blackstone to invest up to $250m in CAR T cell therapy provider Autolus
The financing from Blackstone will support Autolus’ clinical development of obe-cel for relapsed / refractory adult ALL and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Nov 21
The financing from Blackstone will support Autolus’ clinical development of obe-cel for relapsed / refractory adult ALL and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
08 Nov 21
In the Phase 2/3 trial, Paxlovid reduced 89% risk of Covid-19-related hospitalisation or death compared to placebo, within…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Nov 21
Novartis will sell 53.3 million bearer shares of Roche’s common stock, bringing an end to its investment in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 Oct 21
Sandoz obtains rights to three established brands, including Zinnat, Zinacef and Fortum, which had combined sales of around…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Sep 21
With the transaction, the British drugmaker will obtain Caelum’s potential fibril-reactive monoclonal antibody (mAb) CAEL-101 for the treatment…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Sep 21
Merck will obtain Acceleron's medicines for rare diseases, including its pulmonary arterial hypertension (PAH) drug sotatercept
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
22 Sep 21
Novartis said that the acquisition is in line with its strategy of finding treatments for patients with vision…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
22 Sep 21
The new API manufacturing facility for small molecules will be constructed at the Alexion Campus in College Park…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Sep 21
The acquisition will enable Roche to further expand the portfolio with more than 45 CE-IVD assays and more…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
03 Sep 21
The transaction will advance Baxter and Hillrom’s expansion into digital and connected care solutions that enable hospital-level care…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates